Related by context. Frequent words. (Click for all words.) 58 elotuzumab 58 Vilazodone 58 Tripp Levy PLLC 57 Zolinza 57 optical biosensors 56 SNRI 56 multi kinase inhibitor 56 Epratuzumab 56 R sorafenib tablets 56 Aliskiren 56 integrase inhibitors 55 application sNDA 55 subcutaneous formulation 55 Apixaban 55 BMS # 55 selective estrogen receptor 55 Vfend 55 mTOR inhibitor 55 GLPG# 54 long acting beta2 54 Vytorin combines 54 Zyflo 54 BAY #-# 54 muraglitazar 54 insulin sensitizer 54 liposomal formulation 54 Full Prescribing Information 54 selective serotonin reuptake inhibitor 53 Carfilzomib 53 & Korsinsky LLP 53 Dasatinib 53 Fistel LLC Announces 53 Tygacil 53 www.gsk.com 52 Zyvox 52 Lacosamide 52 Goldfarb Branham Law Firm 52 MNTX 52 Boceprevir 52 SNRIs 52 Nexavar ® 52 Zonegran 52 INFORMATION ABOUT THE PROPOSED 52 Eltrombopag 52 Genentech Roche 52 Prozac Paxil 52 manufactures Cialis 52 Myobloc 52 LY# [003] 52 www.syntapharma.com 52 Aptivus 52 Amlodipine 51 Avandaryl 51 VEGF Trap 51 AND OTHER DOCUMENTS FILED 51 elvitegravir 51 Advicor 51 AT HTTP :/ 51 Rebif ® 51 thiazolidinediones 51 Icatibant 51 dalbavancin 51 Hycamtin 51 tyrosine kinase inhibitor 51 atypical antipsychotic 51 vorinostat 51 Bevacizumab 51 triptans 51 Irinotecan 51 Cardizem LA 50 Jon Kamp 50 Maraviroc 50 Caduet 50 SEC BECAUSE THEY 50 GlaxoSmithKline plc GSK 50 Dowd LLP 50 CELANO 50 WWW.SEC.GOV 50 Mipomersen 50 proton pump inhibitors PPIs 50 Tagamet 50 integrase inhibitor 50 bevacizumab Avastin 50 Pravastatin 50 angiogenesis inhibitor 50 Adcirca 50 GV# [001] 50 antidiabetic 50 AstraZeneca Crestor 50 CONTAINS FORWARD LOOKING STATEMENTS 50 SEC WHEN THEY 50 PARP inhibitor 50 pertuzumab 50 glatiramer acetate 50 Bisphosphonates 50 THAT ARE SUBJECT TO 50 Kytril 50 email lrosen@rosenlegal.com 50 erythropoiesis stimulating agents 50 deforolimus 50 Rivaroxaban